Arkolith/Insider Trading/ZIVO/Form 4

Payne John Bernard

President and CEO, DirectorZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Apr 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 3, 2023Buy(P)390K——390K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-23-004461) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML